Success Metrics

Clinical Success Rate
83.3%

Based on 10 completed trials

Completion Rate
83%(10/12)
Active Trials
1(5%)
Results Posted
30%(3 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_3
2
9%
Ph not_applicable
3
14%
Ph phase_4
3
14%
Ph phase_2
8
36%

Phase Distribution

0

Early Stage

8

Mid Stage

5

Late Stage

Phase Distribution16 total trials
Phase 2Efficacy & side effects
8(50.0%)
Phase 3Large-scale testing
2(12.5%)
Phase 4Post-market surveillance
3(18.8%)
N/ANon-phased studies
3(18.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

10 of 15 finished

Non-Completion Rate

33.3%

5 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(3)
Completed(10)
Terminated(5)
Other(4)

Detailed Status

Completed10
unknown4
Withdrawn3
Terminated2
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 28 (50.0%)
Phase 32 (12.5%)
Phase 43 (18.8%)
N/A3 (18.8%)

Trials by Status

terminated29%
unknown418%
withdrawn314%
completed1045%
recruiting15%
enrolling_by_invitation15%
not_yet_recruiting15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07212998Phase 3

Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial

Not Yet Recruiting
NCT07094724Phase 2

High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients

Recruiting
NCT02338986

Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases

Completed
NCT04704869Phase 3

Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation

Completed
NCT06452173

Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis

Enrolling By Invitation
NCT05157724

Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence

Withdrawn
NCT03366220Phase 2

Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock

Terminated
NCT04358783Phase 2

Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia

Completed
NCT02319460

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Completed
NCT02293499Phase 2

Peer Led Asthma Self Management for Adolescents: PLASMA

Completed
NCT04332835Phase 2

Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study

Completed
NCT04332380Phase 2

Convalescent Plasma for Patients With COVID-19: A Pilot Study

Completed
NCT02774317Phase 4

Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months

Withdrawn
NCT02853682

Characterization of Endothelial Dysfunction as a Function of Hyperaemia of the Brachial Artery During Cardiac Surgery

Unknown
NCT02803554Not Applicable

Young Donor Plasma Transfusion and Age-Related Biomarkers

Completed
NCT02037373

Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation

Terminated
NCT02256306Not Applicable

The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study

Completed
NCT03138317Phase 2

Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis

Unknown
NCT02303964Phase 2

Pre-Hospital Use of Plasma for Traumatic Hemorrhage

Withdrawn
NCT00235183Phase 4

Plasma Transfusion in Liver Transplantation

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
22